Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06105632
Title A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Age Groups: adult | senior
Covered Countries USA | CAN | AUS

No variant requirements are available.